Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron
J Infect
.
2024 Apr 24;88(6):106165.
doi: 10.1016/j.jinf.2024.106165.
Online ahead of print.
Authors
Angel Paternina-Caicedo
1
,
David Santiago Quevedo
2
,
Diana Sofía Ríos
2
,
Diane Moyano
2
,
Nelson Alvis-Guzmán
3
,
Nelson Rafael Alviz-Zakzuk
4
,
Fernando Salcedo
4
,
Javier Ramírez-Suarez
5
,
Adrian D Smith
6
,
Fernando De la Hoz-Restrepo
7
Affiliations
1
ALZAK Foundation, Cartagena, Colombia; Universidad del Sinu, Cartagena, Colombia.
2
Secretary of Health, Bogota, Colombia.
3
ALZAK Foundation, Cartagena, Colombia; Universidad de Cartagena, Cartagena, Colombia.
4
ALZAK Foundation, Cartagena, Colombia.
5
Universidad Nacional de Colombia, Bogotá, Colombia.
6
University of Oxford, Oxford, UK.
7
Universidad Nacional de Colombia, Bogotá, Colombia. Electronic address: fpdelahozr@unal.edu.co.
PMID:
38670269
DOI:
10.1016/j.jinf.2024.106165
No abstract available
Publication types
Letter